Home » Topics » Disease categories and therapies » Urology

Urology
RSS

InterMune licenses pirfenidone for fibrotic diseases

April 10, 2002

First patients receive TA-1790 in ED study

April 8, 2002

Positive phase IIa results achieved by HCT-1026 in overactive bladder

April 2, 2002

Inhibitor of TGF-beta activity useful for fibrotic disorders

April 2, 2002

PK/PD of OPC-51803 assessed in patients with urinary incontinence

March 27, 2002

Milkhaus begins phase II trial of ML-04 as treatment of chronic prostatitis

March 27, 2002

NX-1207 shows efficacy in preclinical studies for treatment of benign prostatic hyperplasia

March 26, 2002

Phase III open-label study of Alprox-TD begins in male erectile dysfunction

March 21, 2002

Japanese filing made for sevelamer

March 19, 2002

Keryx initiates phase II dosing of KRX-101 in HIV-associated nephropathy

March 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...